Neurometrix Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

NURO 1.60 -0.03 (-1.84%)
price chart
Insiders Increasing Positions in: NeuroMetrix Inc. (NASDAQ:NURO)
According to the latest SEC filings, insiders at NeuroMetrix Inc. (NASDAQ:NURO) have increased their position in the stock by 8.07% over the past 6 months.
NeuroMetrix, Inc. Announces Date for 2016 Second Quarter Financial Results ...
WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2016 second quarter financial results before the opening of the market on Thursday July 21, 2016.
Are Analysts Bullish Neurometrix Inc (NASDAQ:NURO) After Last Week?
Out of 2 analysts covering Neurometrix (NASDAQ:NURO), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive.
Rodman & Renshaw Starts Neurometrix Inc. (NURO) at Buy
Rodman & Renshaw initiated coverage on Neurometrix Inc. (NASDAQ: NURO) with a Buy rating and a price target of $4.50. Analyst Raghuram Selvaraju thinks the company has a competitive edge in treating chronic pain.
Rodman & Renshaw Sees 160% Upside For NeuroMetrix  Benzinga
Neurometrix Inc 151.4% Potential Upside Now Implied by Rodman & Renshaw  DirectorsTalk Interviews
Revenue Update on Neurometrix Inc(NASDAQ:NURO)
Neurometrix Inc(NASDAQ:NURO) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 21, 2016.
NeuroMetrix Inc. (NURO) Announces Earnings Results  Community Financial News
How Many Neurometrix Inc (NASDAQ:NURO)'s Analysts Are Bullish?  Consumer Eagle
NeuroMetrix Inc. (NURO) to Release Earnings on Thursday
NeuroMetrix logo NeuroMetrix Inc. (NASDAQ:NURO) will be releasing its Q216 earnings data on Thursday, July 21st. NeuroMetrix (NASDAQ:NURO) last released its earnings results on Thursday, April 21st.
NeuroMetrix Inc (NURO) Stock Climbs On Commercialization
NeuroMetrix is having an incredible day in the market today after announcing that it has started the commercialization process in Mexico for a detection system known as DPNCheck.
NeuroMetrix Launches DPNCheck´┐Ż in Mexico with First Government Order  Business Wire (press release)
NeuroMetrix (NURO) Stock Gains After Launching Diabetes Test in Mexico
NeuroMetrix, Inc. (NASDAQ:NURO) Reports $-1.4417 In Comprehensive Income
NeuroMetrix, Inc. (NASDAQ:NURO) registered comprehensive income for the annual period ended 2007-12-31 of $-1.4417 millions.
NeuroMetrix, Inc. (NASDAQ:NURO) Has Been Assigned An ABR Of 1
NeuroMetrix, Inc. (NASDAQ:NURO) stock has bullish outlook. Based on the survey data released by the Zacks as of 2016-07-24, the stock of NeuroMetrix, Inc. (NASDAQ:NURO) has been assigned an ABR of 1 rating. The ABR of one is a signal to go ahead ...
NeuroMetrix Inc.: NeuroMetrix Announces Quell Distribution Agreement with WBC ...
(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that WBC Group, LLC will be the exclusive distributor of Quell Wearable Pain Relief Technology to chiropractors, physical therapists, physical fitness facilities and personal trainers ...